latest news releases from the newsroom
Renewable Energy Trade Board Corporation
CTDC Completes the Disposal of Non-Core Business to Focus in Solar Industry
HONG KONG, Feb. 25, 2009 (GLOBE NEWSWIRE) -- China Technology Development Group Corporation (Nasdaq:CTDC) ("CTDC" or "the Company"), a provider of solar energy products and solutions in China focusing on a-Si thin film technology, today announced that it has completed the disposal of its non-core business of network security on February 16 in order to concentrate solely on its solar energy projects.
Chelsea Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
CHARLOTTE, N.C., Feb. 25, 2009 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that it will release fourth quarter and full year results for the period ended December 31, 2008 before the market opens on Wednesday, March 4, 2009. Chelsea management will host a conference call and live webcast to discuss these financial results and provide an update on each of its development programs later that morning at 11:00 AM ET.
BSD Medical Corporation
BSD Medical to Exhibit At 2009 American College of Radiation Oncology Conference
SALT LAKE CITY, Feb. 25, 2009 (GLOBE NEWSWIRE) -- BSD Medical Corporation (Nasdaq:BSDM) today announced that the company will be exhibiting at the meeting of the American College of Radiation Oncology (ACRO) being held in Las Vegas, Nevada February 26-28. The conference concentrates on the latest clinical and economic information in radiation oncology and seeks to improve the skills of the radiation oncologists. BSD Medical is pleased that ACRO emphasizes the value of the contributions of hyperthermia in treating cancer in combination with radiation therapy by dedicating multiple chapters of its Practice and Management Guide to the topic.
Avigen Announces Positive Data for AV411 in Pain Relief and Drug Addiction
ALAMEDA, Calif., Feb. 25, 2009 (GLOBE NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company, announced today that two preclinical reports with glial attenuator AV411 (ibudilast) support the pharmacological effect of the drug on enhancing the pain-killing effect of opioids while reducing the addiction properties of commonly used opioids such as morphine and oxycodone. Both studies are published online in Brain Behavior and Immunity.
Tix Corporation Announces the Opening of 'Real Pirates' Merchandise Store in Chicago
STUDIO CITY, Calif., Feb. 25, 2009 (GLOBE NEWSWIRE) -- Tix Corporation (Nasdaq:TIXC), a leading integrated entertainment company providing discount and premium ticketing services, event and branded merchandising, and production/promotion of live concert and theatrical events, today announced that its wholly-owned subsidiary Exhibit Merchandising LLC ("Exhibit Merchandising") opened the "Real Pirates" merchandise and gift store in the Chicago Field Museum on Wednesday, February 25, 2009.
QLogic Executive to Present At Seventh Annual Wedbush Morgan Management Access Conference for Micro-Small-Mid-Cap Companies
ALISO VIEJO, Calif., Feb. 25, 2009 (GLOBE NEWSWIRE) -- QLogic Corp. (Nasdaq:QLGC), a leading supplier of high performance network infrastructure solutions, today announced that Simon Biddiscombe, senior vice president and chief financial officer, will present at the Seventh Annual Wedbush Morgan Securities MAC: Management Access Conference for Micro-Small-Mid-Cap Companies on Wednesday, March 11 in New York City at 2:15 p.m. Eastern Time. The conference will be held at the Le Parker Meridien. The event can be accessed through live and archived webcasts via the QLogic web site at http://ir.qlogic.com.